|
| [November 08, 2012] |
 |
Law Office of Brodsky & Smith, LLC Announces Investigation of Schiff Nutrition International, Inc.
BALA CYNWYD, Pa. --(Business Wire)--
Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Schiff Nutrition
International, Inc. ("Schiff" or the "Company") (NYSE: SHF) relating to
the proposed acquisition by Bayer AG ("Bayer").
Under the terms of the transaction, Schiff shareholders will receive
only $34.00 in cash for each share of Schiff common stock they own. The
investigation concerns possible breaches of fiduciary duty and other
violations of state law by the Board of Directors of Schiff for not
acting in the Company's shareholders' best interests in connection with
the sale process to Bayer. The transaction may undervalue the Company as
Schiff announced that sale this fiscal year would increase by 40% to
43% after its acquisition of the cold- prevention remedy Airborne. In
addition, the investigation also seeks to determine if conflicts of
interests played a role in the transaction as Schiff's Board of
Directors has agreed not to solicit any other competing offers.
If you own shares of Schiff stock and wish to discuss the legal
ramifications of the proposed transaction, or have any questions, you
may e-mail or call the law office of Brodsky & Smith, LLC who will,
without obligation or cost to you, attempt to answer your questions. You
may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at
Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004,
by e-mail at investorrelations@brodsky-smith.com
visiting http://brodsky-smith.com/493-shf-schiff-nutrition-international-inc.html,
by calling toll free 877-LEGAL-90.
Attorney Advertising. Past results do not guarantee a similar outcome.
[ Back To HTML5's Homepage ]
|